CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


TB Guidelines

On this Page:


Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United StatesMMWR 2005; 54 (No. RR-15, 49-55)
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDCMMWR 2005; 54 (No. RR-15, 1-37)
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor - Alpha - California, 2002–2003 - MMWR 2004; 53 (No. 30)
Timing of Tuberculosis Screening and Smallpox Vaccination - Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program - MMWR 2003; 52 (No. RR-7)
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection -  MMWR 2000; 49 (No. RR-6)


Archived Testing

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Guidelines for Using the QuantiFERONŽ-TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection - MMWR 2002; 51 (12/18/02)
Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations (ACET) - MMWR 1995;  44 (No. RR-11)


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333